Compare FMC Corp (FMC) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Nomura Holdings Inc — how do they compare? FMC Corp trades at $11.25 (market cap $1.36B), while Nomura Holdings Inc trades at $9.85 (market cap $29.38B). The key difference: Nomura Holdings Inc is far larger — about 21.6× FMC Corp's market cap, and Nomura Holdings Inc pays the higher dividend (3.23%). Which is the better fit depends on your goals.
| FMC | NMR | |
|---|---|---|
Market Cap | $1.36B | $29.38B |
Sector | Basic Materials | Financials |
52-Week High | $43.90 | $10.04 |
52-Week Low | $10.72 | $6.30 |
Enterprise Value | $5.50B | — |
Dividend Yield | 2.95% | 3.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.
The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.
Nomura Holdings (NMR) trades at $9.75, up 1.35% with a bullish technical signal from moving averages. The company reported strong revenue growth to $1.66T in 2025 with a 20.49% net margin, though recent quarters show mixed earnings results with two misses. Analyst consensus leans Hold (66.7%) while technical indicators show RSI levels above 90 suggesting potential overbought conditions.
Outlook remains cautiously optimistic with valuation metrics appearing reasonable (P/E 13.65) and strategic expansion through acquisitions. Key risks include volatile cash flows, rising debt levels, and integration challenges from recent acquisitions. The stock presents value opportunity but requires monitoring of earnings consistency and debt management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
